FEM1B and non-small cell lung carcinoma: In order to further confirm that miR-29b can inhibit the proliferation, invasion, and metastasis of NSCLC cells, FEM1B, miR-29b, si-FEM1B, FEM1B, and FEM1B+miR-29b were transfected into A549 and NCI-H-1792 cells.